solid form selection in the pharmaceutical industry (full length seminar)
Published 4 years ago • 1.7K plays • Length 1:09:38Download video MP4
Download video MP3
Similar videos
-
12:10
solid form selection in the pharmaceutical industry: importance in the drug development process
-
15:25
solid form selection in the pharmaceutical industry: late-appearing and chiral polymorphs
-
13:44
solid form selection in the pharmaceutical industry: solid form characterization techniques (3 of 5)
-
10:56
solid form selection in the pharmaceutical industry: polymorph screening (chapter 2 of 5)
-
16:36
solid form selection in the pharmaceutical industry: nucleation and q&a (chapter 5 of 5)
-
49:27
analytical strategies from early development to validation
-
11:15
key gmp drivers - section 2 of 6
-
1:03:08
speeding drug development through impurity control strategies
-
26:45
solid form suite webinar #2: solid form design in the pharmaceutical industry
-
36:32
forced degradation: breaking it down by paul wrezel ph.d. (full version)
-
21:53
selected case studies and impurity strategies for drug substances by paul wrezel, ph.d. (full)
-
9:08
introduction & purpose of a drug master file (dmf) (1 of 5)
-
23:28
global trends in api and drug product gmps: introduction and overview - section 1 of 6
-
17:19
an overview of pharmaceutical industry
-
2:21
gmps for pharmaceutical excipients - section 4 of 6
-
24:38
direct cnox analysis of solid forms
-
41:56
understanding data integrity (full seminar)
-
6:06
pharma 2.0: how the pharmaceutical industry is embracing technology
-
13:43
fda 505(b)(2) applications seminar part v: quiz time can you identify a (b)(2) application?
-
22:07
content of a drug master file (dmf) (3 of 5)
-
14:31
fda 505(b)(2) applications seminar part viii: q&a and discussion of 505(b)(2) applications